Medicine
R. Agrawal, Rakesh Patel, V. Shah, Lalit Nainiwal, Bhadra Y. Trivedi
tlooto Summary
Hydroxyurea, a myelosuppressive agent, is the only effective drug proven to reduce the frequency of painful episodes and has been used to treat myeloproliferative syndromes-leukemia, melanoma, and ovarian cancer.
Abstract
Abstract is not available.
Citation format
AGRAWAL, R., et al. Hydroxyurea in sickle cell disease: Drug review. Indian Journal of Hematology and Blood Transfusion, 2014, 30: 91–96.